相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer
Marion T. Weigel et al.
BREAST CANCER RESEARCH (2012)
Extended kinase profile and properties of the protein kinase inhibitor nilotinib
Paul W. Manley et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response
Ton van Agthoven et al.
ENDOCRINE-RELATED CANCER (2010)
c-Abl regulates estrogen receptor α transcription activity through its stabilization by phosphorylation
X. He et al.
ONCOGENE (2010)
Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer
Isabel F. Pinhel et al.
BREAST CANCER RESEARCH (2010)
Prognostic Significance of Stromal Platelet-Derived Growth Factor β-Receptor Expression in Human Breast Cancer
Janna Paulsson et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Reciprocal regulation of Abl and receptor tyrosine kinases
Divyamani Srinivasan et al.
CELLULAR SIGNALLING (2009)
Biological determinants of endocrine resistance in breast cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2009)
Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancer
Louis Wing-Cheong Chow et al.
CANCER LETTERS (2008)
Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: Molecular mechanism and clinical implications for endocrine therapy resistance
Grazia Arpino et al.
ENDOCRINE REVIEWS (2008)
Tyrosine Phosphorylation of the Nuclear Receptor Coactivator AIB1/SRC-3 Is Enhanced by Abl Kinase and Is Required for Its Activity in Cancer Cells
Annabell S. Oh et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Platelet-derived growth factor receptor expression and amplification in choroid plexus carcinomas
Nina N. Nupponen et al.
MODERN PATHOLOGY (2008)
Aggressive breast cancer cells are dependent on activated Abl kinases for proliferation, anchorage-independent growth and survival
D. Srinivasan et al.
ONCOGENE (2008)
A phase II placebo-controlled trial of neoadjuvant anastrozole alone or with gefitinib in early breast cancer
Ian E. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Estrogen-independent proliferation is present in estrogen-receptor HER2-positive primary breast cancer after neoadjuvant letrozole
Matthew J. Ellis et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Activation of Abl tyrosine kinases promotes invasion of aggressive breast cancer cells
Divyamani Srinivasan et al.
CANCER RESEARCH (2006)
Autocrine PDGFR signaling promotes mammary cancer metastasis
Martin Jechlinger et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
PDGFRA mutations in gastrointestinal stromal tumors: Frequency, spectrum and in vitro sensitivity to imatinib
CL Corless et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: Influence of hormonal status and HER-2 in breast cancer - A study from the IMPACT trialists
M Dowsett et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Molecular changes in tamoxifen-resistant breast cancer: Relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase
MC Gutierrez et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Overexpression of platelet-derived growth factor receptor a in breast cancer is associated with tumour progression
I Carvalho et al.
BREAST CANCER RESEARCH (2005)
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
A Howell et al.
LANCET (2005)
Mechanisms of disease - Chronic myeloid leukemia - Advances in biology and new approaches to treatment
JM Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Drug therapy: Aromatase inhibitors in breast cancer
IE Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Endocrine-responsive breast cancer and strategies for combating resistance
S Ali et al.
NATURE REVIEWS CANCER (2002)
c-Ab1 has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines
BB Brasher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
